Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 18 547.1 |
96 | EP file number | EAKZ | 01 93 5372.1 |
86 | WO file number | WAKZ | PCT/US01/15326 |
97 | EP publication number | EPN | 1286671 |
87 | WO publication number | WPN | 2001087306 |
54 | Designation/title | TI | PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON KOLOREKTALEM KREBS WELCHE THALIDOMID UND IRINOTECAN ENTHÄLT |
51 | IPC main class | ICM (ICMV) | A61K 31/47 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), A61K 31/445 (2006.01) |
22 | DE application date | DAT | May 10, 2001 |
96 | EP application date | EAT | May 10, 2001 |
86 | WO application date | WAT | May 10, 2001 |
43 | Date of first publication | OT | Nov 22, 2001 |
| Date of publication of grant | PET | Apr 5, 2006 |
71/73 | Applicant/owner | INH | Celgene Corp., Summit, N.J., US; The Board of Trustees of the University of Arkansas, Little Rock, Ark., US |
72 | Inventor | IN | GOVINDARAJAN, Rangaswamy, Little Rock, AR 72223, US; ZEITLIN, Andrew, Basking Ridge, New Jersey 07920, US |
74 | Representative | VTR | Jones Day Rechtsanwälte Patentanwälte, 80538 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060118547T2 Searchable text:
DE000060118547T2 |
| Address for service | | JONES DAY Rechtsanwälte Attorneys-at-Law Patentanwälte, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 204142 P May 15, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001286671 Searchable text:
EP000001286671 Original document:
EP000001286671B1 Searchable text:
EP000001286671B1 Original document: WO002001087306 Searchable text:
WO002001087306 |
43 | Date of first publication | EVT | Nov 22, 2001 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 30, 2018 (Show all update days)(Hide all update days)- Oct 30, 2018; Mar 1, 2017; Jan 17, 2017; Aug 25, 2015; Jun 13, 2015; Mar 31, 2015; Jun 20, 2014; Jun 12, 2014; Aug 2, 2013; Jun 15, 2013; Jun 11, 2013; Jan 24, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 14, 2006 |
71/73 | Applicant/owner | INH | Celgene Corp., Summit, N.J., US; The Board of Trustees of the University of Arkansas, Little Rock, Ark., US |
71/73 | Previous applicant/owner | INHF | Celgene Corp., Warren, N.J., US, The Board of Trustees of the University of Arkansas, Little Rock, Ark., US |